BDBM755340 (R)-2-((S)-2-(5-((3-aminopropyl)amino)isoindolin-2-yl)-2-phenylacetamido)-N-(2,6-difluoro-4-hydroxybenzyl)-5-((Z)-2-(ethylcarbamoyl)guanidino)pentanamide ::US20250213735, Compound 65A

SMILES CCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)[C@H](c1ccccc1)N1Cc2ccc(NCCCN)cc2C1)C(=O)NCc1c(F)cc(O)cc1F

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 755340   

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755340((R)-2-((S)-2-(5-((3-aminopropyl)amino)isoindolin-2...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent